Ligand Pharmaceuticals (LGND) market cap

Market cap today
$5.88B

Ligand Pharmaceuticals (LGND) has a market cap of $5.88B. At the end of fiscal 2025 (December 31, 2025) its market cap was $3.84B. That is 95.8% higher than the $1.96B of fiscal 2024. Today's figure is 53.2% above the fiscal 2025 year-end. Figures as of 18 Nov 2026, 09:41 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Market cap today
$5.88B
Market cap, fiscal 2025
$3.84B
Change on fiscal 2024
+95.8%
Growth, 5 years
+29.7% a year
Growth, 10 years
+5.2% a year
Highest on record
$3.84Bfiscal 2025
Lowest on record
$174.95Mfiscal 2010
Fiscal years on record
172009–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Ligand Pharmaceuticals market cap, in more detail

Over the five fiscal years to 2025 the market cap grew at a compound 29.7% a year; over ten years the rate was 5.2% a year. Across the 17 fiscal year-ends on record (2009–2025), the highest was $3.84B in fiscal 2025 and the lowest $174.95M in fiscal 2010.

History · 17 fiscal years

Market cap at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Ligand Pharmaceuticals market cap, year by year

Ligand Pharmaceuticals (LGND) market cap by fiscal year
Fiscal yearMarket capChangeYear endedShare price at year-endDiluted shares
Today$5.88B—$293.81—
2025$3.84B 95.8% up$189.0720.29M
2024$1.96B 54.5% up$107.1518.29M
2023$1.27B 12.6% up$71.4217.76M
2022$1.13B 32.2% down$66.8016.87M
2021$1.66B 59.2% up$96.3617.25M
2020$1.04B 49.3% down$62.0416.83M
2019$2.06B 36.9% down$65.0631.67M
2018$3.27B 1.6% up$84.6538.58M
2017$3.22B 51.9% up$85.4237.64M
2016$2.12B 8.0% down$63.3933.39M
2015$2.30B 101.8% up$67.6434.03M
2014$1.14B 4.5% up$33.1934.36M
2013$1.09B 165.0% up$32.8133.25M
2012$411.75M 76.0% up$12.9431.82M
2011$234.00M 33.8% up$7.4031.60M
2010$174.95M 28.8% down$5.5631.44M
2009$245.59M—$8.1230.24M

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

How to read it

It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.

Market cap at health care companies of similar size

Market cap of Ligand Pharmaceuticals and comparable companies
CompanyMarket cap
RadNet RDNT$5.90B
Belite Bio BLTE$6.35B
Ligand Pharmaceuticals LGND$5.88B
Scholar Rock Holding SRRK$5.50B
Teleflex TFX$6.33B
Mirum Pharmaceuticals MIRM$6.00B

Today's market value as the market data feed reports it, each in the currency its shares trade in.

More on LGND

Ligand Pharmaceuticals, figure by figure

Ligand Pharmaceuticals (LGND) overview: price, valuation and scorecardAll health care companies by market value

Ligand Pharmaceuticals market cap: questions and answers

What is Ligand Pharmaceuticals's market cap?

Ligand Pharmaceuticals (LGND) has a market cap of $5.88B. At the end of fiscal 2025 (December 31, 2025) its market cap was $3.84B. That is 95.8% higher than the $1.96B of fiscal 2024.

What is the growth rate of Ligand Pharmaceuticals's market cap?

Over the five fiscal years to 2025 the market cap grew at a compound 29.7% a year; over ten years the rate was 5.2% a year.

What are the highest and lowest market cap figures on record for Ligand Pharmaceuticals?

Across the 17 fiscal year-ends on record (2009–2025), the highest was $3.84B in fiscal 2025 and the lowest $174.95M in fiscal 2010.

How is Ligand Pharmaceuticals's market cap calculated?

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote. For Ligand Pharmaceuticals it is on record here for 17 fiscal years, 2009 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Ligand Pharmaceuticals (LGND) market cap”, data as of 18 November 2026. https://funkfolio.com/stock/LGND/market-cap

Underlying data: the company's filings with the SEC and Yahoo Finance.